/PRNewswire/ Lytix Biopharma AS ("Lytix") (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces the election of a new Chairman.
Tuberculosis disease and deaths increased during the COVID-19 pandemic . This has created global demand for rapid tests such as Actiphage® (developed by PBD Biotech) to improve diagnosis of this preventable disease. In response to this need, PBD Biotech is announcing that it has appointed Dr Marie Roskrow to chair .